| |
| |
|
| Insider
Information: |
Gorman Kevin Charles |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
517,112 |
|
|
Indirect Shares
|
57,996 |
|
|
| Direct
Value |
$71,499,465 |
|
|
|
Indirect Value
|
$8,084,642 |
|
|
| Total
Shares |
575,108 |
|
|
| Total
Value |
$79,584,107 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 24.2%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Neurocrine Biosciences Inc |
NBIX |
Chief Executive Office... |
2024-02-13 |
512,052 |
2004-09-22 |
57,996 |
Premium* |
|
|
Xencor Inc |
XNCR |
Director |
2024-02-13 |
5,060 |
2023-06-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
82 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2017-01-10 |
4 |
AS |
$43.28 |
$162,300 |
D/D |
(3,750) |
240,927 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
President and CEO |
• • – |
2016-01-11 |
4 |
AS |
$44.17 |
$165,638 |
D/D |
(3,750) |
221,202 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2017-02-08 |
4 |
OE |
$2.59 |
$166,177 |
D/D |
64,161 |
314,703 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
President and CEO |
• • – |
2016-01-19 |
4 |
AS |
$46.70 |
$175,125 |
D/D |
(3,750) |
224,952 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2022-02-08 |
4 |
AS |
$79.49 |
$180,768 |
D/D |
(2,274) |
462,844 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
officerTitle |
• – – |
2005-12-08 |
4 |
S |
$62.74 |
$188,745 |
D/D |
(3,000) |
55,250 |
|
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2024-02-13 |
4 |
OE |
$35.99 |
$199,951 |
D/D |
5,090 |
512,052 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2019-08-08 |
4 |
OE |
$8.66 |
$228,018 |
D/D |
26,330 |
443,927 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2023-02-08 |
4 |
AS |
$104.30 |
$237,185 |
D/D |
(2,274) |
491,365 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2019-08-07 |
4 |
AS |
$95.12 |
$262,440 |
D/D |
(2,759) |
417,597 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2019-02-04 |
4 |
AS |
$88.10 |
$275,321 |
D/D |
(3,125) |
408,082 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2021-02-05 |
4 |
AS |
$114.16 |
$276,504 |
D/D |
(2,422) |
443,249 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2020-04-24 |
4 |
AS |
$99.45 |
$289,016 |
D/D |
(2,906) |
434,971 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
PRESIDENT AND CEO |
• • – |
2014-12-18 |
4 |
OE |
$2.59 |
$295,150 |
D/D |
70,000 |
195,952 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2018-01-16 |
4 |
AS |
$78.89 |
$295,820 |
D/D |
(3,750) |
336,357 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2023-01-31 |
4 |
AS |
$110.08 |
$297,997 |
D/D |
(2,707) |
465,278 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2024-02-08 |
4 |
AS |
$134.15 |
$305,052 |
D/D |
(2,274) |
506,962 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2020-11-12 |
4 |
AS |
$90.78 |
$307,748 |
D/D |
(3,390) |
441,071 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2023-02-06 |
4 |
AS |
$105.68 |
$321,259 |
D/D |
(3,040) |
468,008 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2020-02-07 |
4 |
AS |
$103.35 |
$335,696 |
D/D |
(3,248) |
432,357 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2018-02-06 |
4 |
D |
$82.48 |
$337,426 |
D/D |
(4,091) |
347,033 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Vice President Business Dev. |
• – – |
2004-02-10 |
4 |
S |
$57.29 |
$344,080 |
D/D |
(6,000) |
55,996 |
|
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2019-02-06 |
4 |
AS |
$84.23 |
$344,986 |
D/D |
(4,096) |
417,597 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
PRESIDENT AND CEO |
• • – |
2014-12-19 |
4 |
AS |
$24.01 |
$360,150 |
D/D |
(15,000) |
180,952 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2024-02-13 |
4 |
AS |
$133.02 |
$376,700 |
D/D |
(2,832) |
514,596 |
0 |
% |
|
82 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
